Learn about the latest research findings. Follow us on Twitter or subscribe to our RSS feed to receive our news releases. Contact our press office to be added to our media list or to arrange an interview.
Latest News
Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl
|
Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50
For younger adults 19 to 30, marijuana, vaping, hallucinogen use are at or near historically high levels
|
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care
|
Xylazine appears to worsen the life-threatening effects of opioids in rats
NIH study deepens understanding of possible mechanism through which xylazine impacts overdose risk
|
Men died of overdose at 2-3 times greater a rate than women in the U.S. in 2020-2021
National data show need for more research into the factors underlying differences in sex-based vulnerability to drug use
|
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people
|